Newsletter Signup | Join Community | Cancer Types
Triple Negative Breast Cancer Foundation
Drs. From Scripps believe that Targaprimir-96 could be the next TNBC treatment?
Interleukin-13 receptor alpha 2 (IL13Ralpha2), biomarker appears active in the growth and spread of TNBC
No Benefit with Addition of Onartuzumab to Taxol® with or without Avastin® in Triple-Negative Breast Cancer
Black Women Have Higher Rates of Triple-Negative Breast Cancer at All Ages
Radiation After Lumpectomy Improves Outcomes Among Elderly with Triple-Negative Breast Cancer
Combination of Iniparib, Gemzar®, & Carboplatin Active in Initial Treatment of Early-Stage Triple-Negative Breast Cancer
Different Pattern of Recurrence for Triple-negative Breast Cancer.
Abraxane® Combo Promising in Triple Negative Breast Cancer.
FDA Seeks to Speed Drug Development for Early-Stage, Triple-Negative Breast Cancer.
Combination of Afinitor and Chemotherapy Shows Promise in Metastatic, Triple-Negative Breast Cancer
Potential New Target Identified in Triple-Negative Breast Cancer
Gene Mutations Common In African American Women with Triple-Negative or Early Onset Breast Cancer
Addition of Carboplatin Improves Outcomes in Triple Negative Breast Cancer
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer
Erbitux plus Chemotherapy Promising in Triple-negative Breast Cancer.
Clinical trial evaluating PARP inhibitor iniparib + chemotherapy did not improve outcomes of metastatic TNBC patients.
Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer
Iniparib Shows Promise Against Triple-Negative Breast Cancer
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they…
Interesting data published this week show HDC appears to benefit TNBC: https://mavendoctors…